LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
9/30/2025 | 6/30/2025 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $270 | $14 | – | – |
| Short-Term Investments | $45 | $0 | – | – |
| Receivables | $0 | $0 | – | – |
| Inventory | $0 | $0 | – | – |
| Other Curr. Assets | $2 | $1 | – | – |
| Total Curr. Assets | $316 | $15 | – | – |
| Property Plant & Equip (Net) | $4 | $4 | – | – |
| Goodwill | $0 | $0 | – | – |
| Intangibles | $0 | $0 | – | – |
| Long-Term Investments | $1 | $0 | – | – |
| Tax Assets | $0 | $0 | – | – |
| Other NC Assets | $0 | $1 | – | – |
| Total NC Assets | $4 | $4 | – | – |
| Other Assets | $0 | $0 | – | – |
| Total Assets | $321 | $19 | – | – |
| Liabilities | – | – | – | – |
| Payables | $3 | $1 | – | – |
| Short-Term Debt | $1 | $1 | – | – |
| Tax Payable | $0 | $0 | – | – |
| Deferred Revenue | $0 | $0 | – | – |
| Other Curr. Liab. | $3 | $3 | – | – |
| Total Curr. Liab. | $7 | $4 | – | – |
| LT Debt | $3 | $3 | – | – |
| Deferred Rev, NC | $0 | $0 | – | – |
| Deferred Tax Liab, NC | $0 | $0 | – | – |
| Other NC Liab. | $1 | $116 | – | – |
| Total NC Liab. | $4 | $119 | – | – |
| Other Liabilities | $0 | $0 | – | – |
| Cap. Leases | $3 | $4 | – | – |
| Total Liabilities | $11 | $123 | – | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | – | – |
| Common Stock | $0 | $0 | – | – |
| Retained Earnings | -$118 | -$115 | – | – |
| AOCI | -$0 | $0 | – | – |
| Other Equity | $428 | $11 | – | – |
| Total Equity | $310 | -$104 | – | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | – | – |
| Total Liab. & Tot. Equity | $321 | $19 | – | – |
| Net Debt | -$266 | -$10 | $0 | $0 |